
Addus HomeCare (ADUS) Stock Forecast & Price Target
Addus HomeCare (ADUS) Analyst Ratings
Bulls say
Addus HomeCare Corp has demonstrated impressive organic revenue growth, with rates of +12.3% year-over-year in 2023 and projected growth of +7.7% and +7.4% for 2024 and 2025 YTD, respectively. The recent +2.6% Medicare Hospice rate increase effective October 1, 2025, is expected to provide additional financial support to the company's Hospice segment, which is anticipated to maintain revenue growth of +5% to +7%. Furthermore, strategic mergers and acquisitions, alongside operational enhancements from recent leadership changes, are poised to drive further expansion and profitability for the company.
Bears say
Addus HomeCare Corp's stock faces a negative outlook due to ongoing same-store declines attributed to administrative bottlenecks in patient onboarding, resulting from Medicaid redeterminations that have led to higher discharge rates compared to admissions. The company’s dependence on Medicaid funding, which constitutes approximately 97% of its segment revenues for the year to date in 2025, creates uncertainty regarding future revenue stability amidst legislative changes such as the One Big Beautiful Bill Act. Despite demonstrating steady operational execution and a business model aligned with long-term demand trends, the disconnect between equity valuation and underlying financial performance remains a significant concern for investors.
This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.
Addus HomeCare (ADUS) Analyst Forecast & Price Prediction
Start investing in Addus HomeCare (ADUS)
Order type
Buy in
Order amount
Est. shares
0 shares